Man's sight returns with Advanced Cell's stem cell treatment

05/21/2013 | New Scientist

An experimental stem cell treatment developed by Advanced Cell Technology restored the sight of a man who suffered retinal cell degeneration, according to the company. The patient is part of a trial testing the safety of stem cell-derived retinal pigment epithelial cells in reversing damage caused by dry age-related macular degeneration or Stargardt's macular dystrophy, two common causes of blindness. The vision in the man's affected eye is said to have improved from 20/400 to 20/40.

View Full Article in:

New Scientist

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Children's Health Plan
Houston, TX
Actuary
NTA Life
Addison, TX
Manager of Payer Relations
Pharmacy Quality Solutions, Inc.
Raleigh/Durham, NC
Director of Product Planning Development; Market Planning, Innovation
Blue Cross Blue Shield of Massachusetts
Quincy , MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ